NM_032601.4(MCEE):c.376G>A (p.Glu126Lys) AND Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Sep 1, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001350396.6

Allele description [Variation Report for NM_032601.4(MCEE):c.376G>A (p.Glu126Lys)]

NM_032601.4(MCEE):c.376G>A (p.Glu126Lys)

Gene:

MCEE:methylmalonyl-CoA epimerase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2p13.3

Genomic location:

Preferred name:

NM_032601.4(MCEE):c.376G>A (p.Glu126Lys)

HGVS:

NC_000002.12:g.71124208C>T
NG_008977.1:g.11057G>A
NM_032601.4:c.376G>AMANE SELECT
NP_115990.3:p.Glu126Lys
NC_000002.11:g.71351338C>T

Protein change:

E126K

Links:

dbSNP: rs779113206

NCBI 1000 Genomes Browser:

rs779113206

Molecular consequence:

NM_032601.4:c.376G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency
Synonyms:: METHYLMALONYL-CoA RACEMASE DEFICIENCY; METHYLMALONIC ACIDURIA III; Methylmalonyl-CoA epimerase deficiency
Identifiers:: MONDO: MONDO:0009615; MedGen: C1855100; OMIM: 251120

Recent activity

Clear Turn Off Turn On

Quackery
Quackery
The fraudulent misrepresentation of the diagnosis and treatment of disease.<br/>

MeSH
Social Status
Social Status
The relative prestige, authority, and privilege of an individual or group.<br/>Year introduced: 2022

MeSH
Social Network Analysis
Social Network Analysis
A set of methods that identify the ties or relationships linking each member of a group to every other member.<br/>Year introduced: 2021

MeSH
c-Myb and oncogenic variant v-Myb transcriptional activities
c-Myb and oncogenic variant v-Myb transcriptional activities
Accession: GDS1427

GEO DataSets
Related DataSets for GEO Profiles (Select 14100976) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001544793	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Sep 1, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001544793

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Sep 1, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001544793.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces glutamic acid with lysine at codon 126 of the MCEE protein (p.Glu126Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs779113206, ExAC 0.02%). This variant has not been reported in the literature in individuals affected with MCEE-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine